Atara Biotherapeutics Inc. buy BiotechBee
Start price
01.10.23
/
50%
€1.41
Target price
31.01.26
€3.00
Performance (%)
-74.00%
Price
18.06.24
€0.37
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Atara Biotherapeutics Inc. is performing very badly with a performance of -74.00%. This prediction currently runs until 31.01.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Atara Biotherapeutics Inc. | - | - |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
According to BiotechBee what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Atara Biotherapeutics Inc. diskutieren
Buy mit Kursziel 3,0